F-star Therapeutics CEO Eliot Forster at EUBIO22 (Rachel Kiki for Endpoints News)

December 29, 2022 10:31 AM ESTUpdated December 30, 01:01 PM

Updated: US puts hold on F-star's takeover by China’s Sino Biopharm, citing national security risks

Drew Armstrong

Executive Editor

F-star Therapeutics won’t yet be able to close its deal with its Chinese buyer, after the US government’s Committee on Foreign Investment in the United …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Updated: US puts hold on F-star's takeover by China’s Sino Biopharm, citing national security risks

Drew Armstrong

Executive Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Are programs with compounded GLP-1s safe for your population?

Up­dat­ed: US puts hold on F-star's takeover by Chi­na’s Sino Bio­pharm, cit­ing na­tion­al se­cu­ri­ty risks

Drew Armstrong

Executive Editor

Sign up to read this article for free.

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Updated: US puts hold on F-star's takeover by China’s Sino Biopharm, citing national security risks

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Are programs with compounded GLP-1s safe for your population?